CERO
Cero Therapeutics Holdings, Inc.Company with tickers: CERO, CEROW
CIK
1870404
CUSIP
71902K402
Shares Outstanding
45,112,406
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-04 | Francois Eric |
Chief Financial Officer | Award | 1,823,278 |
| 2026-02-13 | Francois Eric |
Chief Financial Officer | Other | 0 |
| 2026-01-07 | Ehrlich Christopher B |
Director, Chief Executive Officer | Award | 4,530,997 |
| 2026-01-07 | Rolfe Lindsey |
Director | Award | 690,900 |
| 2026-01-07 | Byrnes Michael |
Director | Award | 690,900 |
| 2026-01-07 | LAPORTE KATHLEEN |
Director | Award | 690,900 |
| 2026-01-07 | Pierce Kristen |
Chief Development Officer | Award | 1,612,099 |
| 2026-01-07 | KUCHARCHUK ANDREW ALBERT |
Director | Award | 1,162,099 |
| 2026-01-07 | ATWOOD BRIAN G |
Director | Award | 1,612,099 |
| 2026-01-07 | Patel Shami |
Insider | Award | 690,900 |
| 2025-05-30 | Pierce Kristen |
Chief Development Officer | Award | 154,841 |
| 2025-05-30 | ATWOOD BRIAN G |
Director | Award | 122,549 |
| 2025-05-30 | LAPORTE KATHLEEN |
Director | Award | 9,326 |
| 2025-05-30 | Patel Shami |
Insider | Award | 11,693 |
| 2025-05-30 | Rolfe Lindsey |
Director | Award | 9,326 |
| 2025-05-30 | KUCHARCHUK ANDREW ALBERT |
Director | Award | 152,500 |
| 2025-05-30 | Byrnes Michael |
Director | Award | 9,326 |
| 2025-05-30 | Ehrlich Christopher B |
Director, Chief Executive Officer | Award | 61,843 |
| 2025-03-31 | ATWOOD BRIAN G |
Director | Convert | 294,460 |
| 2025-03-31 | ATWOOD BRIAN G |
Director | Other | 204,080 |
| 2025-03-31 | ATWOOD BRIAN G |
Director | Other | 1,250 |
| 2025-03-31 | ATWOOD BRIAN G |
Director | Convert | 294,460 |
| 2025-03-04 | Patel Shami |
Insider | Award | 14,936 |
| 2025-03-04 | Byrnes Michael |
Director | Award | 17,923 |
| 2025-03-04 | Ehrlich Christopher B |
Director, Chief Executive Officer | Award | 119,486 |
| 2025-03-04 | Rolfe Lindsey |
Director | Award | 17,923 |
| 2025-03-04 | LAPORTE KATHLEEN |
Director | Award | 17,923 |
| 2025-03-04 | ATWOOD BRIAN G |
Director | Award | 14,936 |
| 2025-02-24 | ATWOOD BRIAN G |
Director | Award | 254,000 |
| 2025-02-24 | Rolfe Lindsey |
Director | Award | 127,500 |
| 2025-02-24 | Ehrlich Christopher B |
Director, Chief Executive Officer | Award | 1,275,000 |
| 2025-02-24 | Byrnes Michael |
Director | Award | 127,500 |
| 2025-02-24 | LAPORTE KATHLEEN |
Director | Award | 127,500 |
| 2025-02-24 | Patel Shami |
Insider | Award | 127,500 |
| 2025-02-07 | ATWOOD BRIAN G |
Director | Award | 306,120 |
| 2025-02-07 | ATWOOD BRIAN G |
Director | Award | 306,120 |
| 2025-02-07 | ATWOOD BRIAN G |
Director | Award | 204,080 |
| 2025-02-07 | ATWOOD BRIAN G |
Director | Award | 204,080 |
| 2024-12-13 | YK Bioventures Opportunities GP I, LLC |
10% Owner | Sell | 2,998,908 |
| 2024-12-12 | YK Bioventures Opportunities GP I, LLC |
10% Owner | Sell | 1,614,541 |
| 2024-12-11 | YK Bioventures Opportunities GP I, LLC |
10% Owner | Sell | 1,343,801 |
| 2024-12-10 | YK Bioventures Opportunities GP I, LLC |
10% Owner | Sell | 1,570,947 |
| 2024-12-09 | YK Bioventures Opportunities GP I, LLC |
10% Owner | Sell | 850,543 |
| 2024-12-06 | YK Bioventures Opportunities GP I, LLC |
10% Owner | Sell | 1,236,874 |
| 2024-12-02 | LAPORTE KATHLEEN |
Director | Award | 127,500 |
| 2024-12-02 | Patel Shami |
Insider | Award | 127,500 |
| 2024-12-02 | ATWOOD BRIAN G |
Director | Award | 254,000 |
| 2024-12-02 | Rolfe Lindsey |
Director | Award | 127,500 |
| 2024-12-02 | Ehrlich Christopher B |
Director, Chief Executive Officer | Award | 1,275,000 |
| 2024-12-02 | Byrnes Michael |
Director | Award | 127,500 |
Showing 1–50 of 151 transactions